GGrantIndex
Sort

172,184 grants matching inflammation

Pathogenesis and countermeasures of poxviruses, hemorrhagic fever viruses, MERS

$1,054,912
Peter Jahrling · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI

Theoretically Informed Behavioral Intervention to Enhance QOL and Prevent HIV-related Comorbidities in Ethnic and Racial Sexual Minority Men

$1,054,907
Silvia Raquel Ramos · Yale University · R01 · FY2024 · MD

TL1A and its receptor DR3 in normal and autoimmune T cell responses

$1,054,860
Richard M Siegel · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2014 · AR

Determinants of inception of inflammation in inflammatory bowel diseases

$1,054,797
Ashwin N Ananthakrishnan · Massachusetts General Hospital · R01 · FY2024 · DK

Mentoring Research Excellence in Aging and Regenerative Medicine

$1,054,761
S Michal Jazwinski · Tulane University Of Louisiana · P30 · FY2023 · GM

Airway Alkalinization and Repurposing Tromethamine as a Therapeutic Approach in Cystic Fibrosis

$1,054,599
David A Stoltz · University Of Iowa · R01 · FY2020 · HL

Therapeutic Neutralization of the Inflammasome After Spinal Cord Injury

$1,054,411
Robert W Keane · Inflamacore, Llc · R42 · FY2015 · NS

Development of Sotair for Improving Performance and Minimizing Complications of Manual Ventilation

$1,054,335
Prathamesh Prabhudesai · Safebvm Corp. · R44 · FY2022 · HL

Study the pathogenesis of neurological disorders using human neural cultures derived from patient peripheral blood CD34 cells

$1,054,273
Avindra Nath · National Institute Of Neurological Disorders And Stroke · ZIA · FY2020 · NS

Cell-Surface Interactions in Pathogenesis

$1,054,254
Kenneth Yamada · National Institute Of Dental & Craniofacial Research · ZIA · FY2021 · DE

PET IMAGING OF SYNAPTIC DENSITY COMBINED WITH NEUROIMMUNOLOGIC MEASURES TO REVEAL MECHANISMS OF HIV NEUROPATHOGENESIS DURING ART

$1,054,215
Serena S Spudich · Yale University · R01 · FY2022 · MH

Mutographs differentiating the racial and temporal incidence of multiple myeloma

$1,054,153
Gareth John Morgan · New York University School Of Medicine · R01 · FY2024 · CA

Function of Toll-Like Receptors Throughout Gestation

$1,054,061
Gil G Mor · Yale University · P01 · FY2012 · HD

Collaborative Protein Technology Resource - Nano-Scale Protein Analysis Section

$1,053,823
Noemi Kedei · Division Of Basic Sciences - Nci · ZIC · FY2021 · CA

Immunity to Pneumonic Tularemia

$1,053,791
Catharine Bosio · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI

Sex and APOE genotype interact to alter immune regulated metabolism in AD

$1,053,608
Carol A Colton · Duke University · R56 · FY2017 · AG

Airway Alkalinization and Repurposing Tromethamine as a Therapeutic Approach in Cystic Fibrosis

$1,053,550
David A Stoltz · University Of Iowa · R01 · FY2021 · HL

The epigenetic regulation of inflammation in tissue repair and vascular disease

$1,053,460
Katherine Ann Gallagher · University Of Michigan At Ann Arbor · R35 · FY2024 · HL

India International Center for Excellence in Research

$1,053,276
Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI

A Laser Microbeam Biotechnology Resource

$1,052,908
Bruce J Tromberg · University Of California-Irvine · P41 · FY2016 · EB

Mucins and immune cell interactions in ovarian cancer pathogenesis & progression

$1,052,893
Daniel William Cramer · Brigham And Women'S Hospital · R35 · FY2016 · CA

Multimodal microPET and microMRI Imaging Instrumentation

$1,052,834
Russell E Jacobs · California Institute Of Technology · R01 · FY2012 · EB

Molecular Mechanisms Of Cell Adhesion And Invasion

$1,052,490
Steven K Akiyama · Environmental Health Sciences · Z01 · FY2007 · ES

Effects of Multi-Modal Exercise Intervention Post Hip Fracture

$1,052,355
Jay Steven Magaziner · University Of Maryland Baltimore · R37 · FY2011 · AG

Advancing Epilepsy Diagnosis with Flexible, High-Resolution Thin-Film Electrodes

$1,052,315
Daniel Friedman · New York University School Of Medicine · UG3 · FY2025 · NS